Multizentrische Anwendungsbeobachtung zum Einsatz eines topischen Kombinationspräparates aus Mometasonfuroat 0,1 % und Salicylsäure 5 % bei der Behandlung von mittelschwerer bis schwerer Psoriasis

Abstract

In a multicenter observational study the effectiveness, safety and tolerability of a mometasone furoate 0.1 % - salicylic acid 5 % ointment in topical treatment of 3652 patients with moderate to severe psoriasis was assessed. During 4 weeks of topical treatment all clinical symptoms of psoriasis improved. Global clinical impression was good to excellent in more than 87 % of patients. In line, more than 84 % of patients were at least satisfied with the combined topical treatment. Less than 0.4 % of patients reported minor side effects. Taken together, these findings support the safety and efficacy of topical treatment with mometasone furoate 0.1 % - salicylic acid 5 % ointment, and suggest that this well-tolerated fixed combination is a useful addition to topical therapy of psoriasis patients in everyday practice.